Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Pat Cash Raises the Bar on AusBiz TV Show Australia - Proving He is Not Only a Pro Tennis Player But is a Man On a Mission, With a Bag of Knowledge


News provided by

Pat Cash CBD

Mar 12, 2024, 10:15 ET

Share this article

Share toX

Share this article

Share toX


Pat Cash is the first major sports celebrity in the world with his own range of CBD products branded under his own name. Cash is driven by the need to create a vast platform across the world to help people suffering illness by use of his health products.

SYDNEY, March 12, 2024 /PRNewswire-PRWeb/ -- The 1987 Wimbledon Men's Singles tennis champion Pat Cash announced on Australian television show AusBiz that he is launching his own CBD product range, and that he is looking for medicinal cannabis companies and distributors to partner with.

Pat Cash is the first major sports celebrity in the world with his own range of CBD products branded under his own name.

I would like to make CBD more readily available for pain relief, anxiety, and all the things it's great for. This is why I set up this health company. We need to lobby the Australian government and other countries too, to make it more readily available to those who need it.

Post this

Cash is driven by the need to create a vast platform across the world to help people suffering illness by use of his health products. And he has been to hell and back with his own personal injuries that have forced him to make the transition into creating the first of many products to come in his health range.

On AusBiz he shared how he has just had his seventh knee injury, and about the wear and tear he has put his body through from more than 40 years competing at the highest level.

Cash like most athletes has always had access to the latest advances in sports medicine, and the most effective products to aid recovery, and one compound that has helped him more than any other is CBD.

As he explained:

"For an athlete with lots of injuries, lots of anxiety, and who struggled to sleep, what's going to work? CBD oil ticked every box for me. It's something that has really worked for me."

"I came across CBD while looking for something natural to help me sleep, and as an alternative to painkillers. We are seeing athletes lining up for this. Athletes are telling us, they don't want to take pills, they don't want sleeping pills anymore. So, we wanted to create a product with anti-inflammatory properties, and with zero THC.

If athletes have access to the best medicinal products in the world and at strengths that give real results, then why not everybody else? And it's his own personal experiences with CBD that have lead Cash to want to share these same benefits with as many people around the world as possible, and at a price that everybody can afford.

Hemp has already been used for thousands of years for a variety of conditions and has amazing medicinal properties.

Cash explained how there is a huge need for medicinal cannabis, and doctors are finally realizing it is natural and that cannabis is not a dirty word anymore. There's also been a massive boom in cannabis prescriptions in Australia and many other countries.

"The anxiety levels that people experience is going through the roof, especially after the pandemic, in young people and older people too—and they need help."

Cash is a man on a mission and he has set his sights on becoming the global spokesman for the CBD and medical cannabis industry.

"I would like to make CBD more readily available for pain relief, anxiety, and all the things it's great for. This is why I set up this health company. We need to lobby the Australian government and other countries too, to make it more readily available to those who need it."

In a world governed by regulations Cash has got his work cut out for him, but there is no doubt when watching the AusBiz interview that Cash has got exactly what it takes. Born a champion to create champions.

It's obvious that Cash has a new vocation in his life to create the benchmark within the industry and to become a spokesman for the people.

If it's simply about time with regards to conquering, then time I believe is all Cash needs.

* Watch Pat Cash's interview on the AusBiz TV show: www.patcashcbd.com/pages/au-nz-media
* For further information about Pat Cash's products visit: www.patcashcbd.com
* For distribution and all commercial enquiries: www.patcashcbd.com/pages/contact

Media Contact

Mike Pettigrew, Pat Cash CBD, 1 630-454-1707, [email protected], https://patcashcbd.com/

SOURCE Pat Cash CBD

Modal title

Pat Cash International Tennis Champion
Pat Cash International Tennis Champion
Pat Cash is Interviewed on AusBiz TV Show
Pat Cash is Interviewed on AusBiz TV Show
Pat Cash on AusBiz TV Show
Pat Cash on AusBiz TV Show
Pat Cash CBD Product Range
Pat Cash CBD Product Range
Pat Cash CBD - Active Relief 15
Pat Cash CBD - Active Relief 15
Pat Cash International Tennis Champion Pat Cash is Interviewed on AusBiz TV Show Pat Cash on AusBiz TV Show Pat Cash CBD Product Range Pat Cash CBD - Active Relief 15

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.